EMEA-001195-PIP01-11-M04

Key facts

Invented name
Feraccru
Active substance
ferric maltol
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0330/2019
PIP number
EMEA-001195-PIP01-11-M04
Pharmaceutical form(s)
  • Capsule, hard
  • Oral suspension
Condition(s) / indication(s)
Treatment of iron deficiency anaemia (IDA)
Route(s) of administration
Oral use
Contact for public enquiries
Norgine BV

Tel. +44 (0)1895 826600
E-mail: lifecyclemanagement@norgine.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating